Axl-IN-17 (compound 13c) is an orally active, selective AXL inhibitor with an IC 50 value of 3.2 nM. Axl-IN-17 reveals antitumor efficacy.
Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > TAM Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.